Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “therapy”

782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 782
Index total 30,257
Page 22 / 33

Quick answer

This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

782 results for “therapy” · 30,257 patents in full index Clear search

  1. US 9458442

    Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

    HALOZYME, INC. · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  2. US 9458215

    Compositions and methods for osteogenic gene therapy

    The United States of America as represented by the Department of Veteran Affairs · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  3. US 9452182

    Collateral gene inactivation biomarkers and targets for cancer therapy

    The Board of Regents of the University of Texas System · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted

  4. US 9433666

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted

  5. US 9428541

    Substrate reduction therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted

  6. US 9415123

    Polymeric nanoparticles for ultrasound imaging and therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted

  7. US 9404081

    Pyruvate kinase activators for use in therapy

    Agios Pharmaceuticals, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  8. US 9399662

    Concurrent chemotherapy and immunotherapy

    The Board of Regents of the University of Texas System · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted

  9. US 9375438

    Inhibitors of NCCa-ATP channels for therapy

    The United States of America as Represented by the Dept. of Veterans Affairs · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted

  10. US 9375475

    Combination immunotherapy for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted

  11. US 9364462

    Alpha-1-adrenergic receptor agonist therapy

    The Regents of the University of California · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted

  12. US 2016159901

    DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS

    GANYMED PHARMACEUTICALS AG [DE] · Granted Jun 9, 2016 · Expires Jun 4, 2036

    granted

  13. US 9358285

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 7, 2016 · Expires Jun 2, 2036

    granted

  14. US 9346875

    Therapy for filovirus infection

    The United States of America as represented by the Secretary of the Army · Granted May 24, 2016 · Expires May 19, 2036

    granted

  15. US 9315534

    Radiologic agents for monitoring alzheimer's disease progression and Evaluating a Response to Therapy and processes for the preparation of such agents

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  16. US 9290541

    TCL1 peptides for immunotherapy

    The Board of Regents of the University of Texas System · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted

  17. US 9271985

    Method of using vasoconstrictive agents during energy-based tissue therapy

    Covidien LP · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  18. US 9259452

    Deacetylase inhibitor therapy

    THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted

  19. US 9233103

    Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted

  20. US 9211419

    Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy

    The Board of Regents of the University of Texas System · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  21. US 9198893

    Combination antitumor therapy

    Galera Labs, LLC · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  22. US 9193701

    Pyruvate kinase activators for use in therapy

    Agios Pharmaceuticals, Inc. · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  23. US 9180161

    CAR peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disorders

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  24. US 9180122

    5- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and pain

    Takeda Pharmaceutical Company Limited · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.